Stay updated on Velaglucerase Alfa for Type 1 Gaucher Clinical Trial

Sign up to get notified when there's something new on the Velaglucerase Alfa for Type 1 Gaucher Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Velaglucerase Alfa for Type 1 Gaucher Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page footer was updated to reflect a newer ClinicalTrials.gov site revision (from v3.5.2 to v3.5.3).
    Difference
    0.0%
    Check dated 2026-04-26T15:38:27.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T13:57:58.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Added the term Gaucher disease type I as a keyword on the page to reflect the specific condition studied.
    Difference
    0.1%
    Check dated 2026-03-29T03:40:26.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed. This reflects a site versioning update and does not modify the study details or user interactions.
    Difference
    0.0%
    Check dated 2026-03-21T19:19:32.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T07:59:23.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. No other visible changes to the page content.
    Difference
    0.0%
    Check dated 2026-02-14T01:52:11.000Z thumbnail image

Stay in the know with updates to Velaglucerase Alfa for Type 1 Gaucher Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Velaglucerase Alfa for Type 1 Gaucher Clinical Trial page.